UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000005765
Receipt number R000006815
Scientific Title Cone-beam CT assisted needle interventions
Date of disclosure of the study information 2011/06/13
Last modified on 2014/01/06 09:49:16

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Cone-beam CT assisted needle interventions

Acronym

Cone-beam CT assisted needle interventions

Scientific Title

Cone-beam CT assisted needle interventions

Scientific Title:Acronym

Cone-beam CT assisted needle interventions

Region

Japan


Condition

Condition

unresectable hepatic tumor

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the safety and utility of cone-beam CT assisted needle interventions

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Clinical utility

Key secondary outcomes

Safety


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

C-arm cone-beam CT assisted needle interventions provides us patentially utilities for targeting lesions.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Eligibility criteria unresectable hepatic tumor
age >20 year-old
1) maximum diameter < 5cm, and tumor number <3 nodules
2) no evidence of uncontrollable ascites
3) no evidence of respiratory failure and heart failure

Key exclusion criteria

1) platelet count<50,000/microl,prothrombin time<80%
2) Patient with difficult communication

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Manabu Morimoto

Organization

Yokohama City University Medical Center

Division name

Gastroenterological Center

Zip code


Address

4-57 Urafune-cho, Minami-ku, Yokohama City, 232-0024, Japan

TEL

045-261-5656

Email

m-morimoto@kcch.jp


Public contact

Name of contact person

1st name
Middle name
Last name Manabu Morimoto

Organization

Yokohama City University Medical Center

Division name

Gastroenterological Center

Zip code


Address

4-57 Urafune-cho, Minami-ku, Yokohama City, 232-0024, Japan

TEL

045-261-5656

Homepage URL


Email

m-morimoto@kcch.jp


Sponsor or person

Institute

Yokohama City University Medical Center

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

横浜市立大学附属市民総合医療センター(神奈川県)


Other administrative information

Date of disclosure of the study information

2011 Year 06 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2011 Year 06 Month 01 Day

Date of IRB


Anticipated trial start date

2011 Year 06 Month 01 Day

Last follow-up date

2016 Year 05 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2011 Year 06 Month 13 Day

Last modified on

2014 Year 01 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006815


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name